All Registry communications to: Automic Group GPO Box 5193 Sydney NSW 2001 Telephone (free call within Australia): 1300 288 664 ASX Code: ATH 21 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder, Alterity Therapeutics Limited, ACN 080 699 065 (ASX: ATH or “the...
Alterity Therapeutics: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 43 pages · English
Summary by 6ix AI
Alterity Therapeutics Ltd. has issued a notice for its upcoming Annual General Meeting, scheduled to take place in November. The notice includes details on resolutions to be voted on, including the adoption of the remuneration report and the re-election of directors. Shareholders are encouraged to submit proxy votes and questions in advance to facilitate the meeting. The document outlines the voting procedures and important dates for shareholders to consider.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Alterity Therapeutics Ltd. on 6ix
Story so far
Earlier from Alterity Therapeutics
- Changes to Managing Director Terms of Employment
- Alterity to Present at the Craig-Hallum Biotech Conference
- Alterity to Present at Canaccord Drug and Device Conference
- Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
- Alterity Presents New Analyses of ATH434 Phase 2 Data in MSA
Later from Alterity Therapeutics
- Notification regarding unquoted securities - ATH
- Proposed issue of securities - ATH
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics